Literature DB >> 6435551

Lumpectomy and level I axillary dissection prior to irradiation for "operable" breast cancer.

G F Schwartz, A L Rosenberg, B F Danoff, C M Mansfield, S A Feig.   

Abstract

Between July 1, 1979 and March 1, 1984, we treated 154 women by irradiation as an alternative to mastectomy. Excision of the primary tumor without the sacrifice of a large volume of contiguous normal breast (lumpectomy) was performed, and all but ten women also underwent concomitant level I axillary node dissection. The mean node count in the level I dissection was 27 nodes, indicating that this dissection offered accurate information about axillary node status, so that the extent of radiation therapy and subsequent adjuvant chemotherapy could be planned appropriately. Subdivision of the level I nodes into anatomic groups and their separate histologic analysis suggested that less than a complete level I dissection might miss involved nodes in almost one-half the patients with clinically negative axillae but histologically positive nodes. Postoperative complications occurred in 13% of patients, not an insignificant number, most of them being either infections or the persistent accumulation of lymph in the axillary wound. Later complications, such as infection or arm edema, also occurred, just as after mastectomy. The median follow-up of these 154 patients has been only 12 months, the maximum being not quite 5 years, so that any long-term speculations are not justified. We believe that the continued use of this combination therapy is warranted preceding irradiation by lumpectomy and level I axillary dissection as described, with careful follow-up to assess the long-term results of this option.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6435551      PMCID: PMC1250529          DOI: 10.1097/00000658-198410000-00016

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  1 in total

1.  Comparing radical mastectomy with quadrantectomy, axillary dissection, and radiotherapy in patients with small cancers of the breast.

Authors:  U Veronesi; R Saccozzi; M Del Vecchio; A Banfi; C Clemente; M De Lena; G Gallus; M Greco; A Luini; E Marubini; G Muscolino; F Rilke; B Salvadori; A Zecchini; R Zucali
Journal:  N Engl J Med       Date:  1981-07-02       Impact factor: 91.245

  1 in total
  5 in total

1.  General surgery: conservative surgical treatment of carcinoma of the breast.

Authors:  J J Coyle
Journal:  West J Med       Date:  1985-04

2.  Conservative treatment for breast cancer. Complications requiring reconstructive surgery.

Authors:  J Bostwick; C Paletta; C R Hartrampf
Journal:  Ann Surg       Date:  1986-05       Impact factor: 12.969

3.  Incidence of gross and microscopic carcinoma in specimens from patients with breast cancer after re-excision lumpectomy.

Authors:  J L Gwin; B L Eisenberg; J P Hoffman; F D Ottery; M Boraas; L J Solin
Journal:  Ann Surg       Date:  1993-12       Impact factor: 12.969

4.  Current status of conservative surgery and radiotherapy as primary local treatment for early carcinoma of the breast.

Authors:  J R Harris; A Recht; S Schnitt; J Connolly; B Silver; S Come; I C Henderson
Journal:  Breast Cancer Res Treat       Date:  1985       Impact factor: 4.872

5.  Biological markers of risk in nipple aspirate fluid are associated with residual cancer and tumour size.

Authors:  E R Sauter; H Ehya; J Babb; E Diamandis; M Daly; A Klein-Szanto; E Sigurdson; J Hoffman; J Malick; P F Engstrom
Journal:  Br J Cancer       Date:  1999-12       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.